Genetic and Technical Aspects of the HLA System and Its Possible Role in Human Malignancy

References

• Doan C A. The recognition of a biological differentiation in the whole blood cells with special reference to blood transfusion. J Am Med Assoc 1926; 86: 1593
   Google Scholar
• Dausset J, Nenna A. Presence d'une leuco-agglutinine dans le serum d'un cas d'agranulocytose chronique. Soc Biol (Paris) 1952; 146: 1539
   PubMedGoogle Scholar
• Dausset J. Iso-leuco-anticorps. Acta Haematol 1958; 20: 156
   PubMedGoogle Scholar
• Pleogh H L, Orr H T, Strominger J L. Molecular cloning of a human histocompatibility antigen cDNA fragment. Proc Natl Acad Sci USA, 77: 6081–6085
   PubMed Web of Science ®Google Scholar
• Hurley C K, Munez G, Winchester R, et al. The human HLA-DR antigens are encoded by multiple B-chain loci. J Immunol 1982; 129: 2103–2108
   PubMed Web of Science ®Google Scholar
• Shackelford D A, Kaufman J F, Korman A J, et al. HLA-DR antigens: Structure, separation of subpopulations, gene cloning and function. Immunol Rev 1982; 66: 133–187
   PubMed Web of Science ®Google Scholar
• Orr H T, Lopez De Castro J A, Parham P, et al. Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: Location of putative alloantigenic sites. Proc Natl Acad Sci USA 1979; 76: 4395–4399
   PubMed Web of Science ®Google Scholar
• Cotner T, Mashimo H, Kung P C, et al. Human T cell surface antigens bearing a structural relationship to HLA antigens. Proc Natl Acad Sci USA 1981; 78: 3858–3862
   PubMed Web of Science ®Google Scholar
• Lerch P G, Van De Rijn M, Schrier P, Terhorst C. Biochemical comparison of the T6 antigen and HLA-A.B antigens. Human Immunol 1983; 6: 13–30
   PubMed Web of Science ®Google Scholar
• Trapani J A, Vaughan H A, Sparrow R L, et al. Description of a mouse monclonal anti-HLA-B27 antibody HLA-ABC-m3. Human Immunol 1983; 7: 205–216
   PubMed Web of Science ®Google Scholar
• Muller C, Herbst H, Loffler G, et al. A cytotoxic monoclonal antibody specific for the private alloantigenic determinant of the HLA-B 13 molecule. Human Immunol 1983; 7: 229–237
   PubMed Web of Science ®Google Scholar
• Richiardi P, Crepaldi T, Malavasi F, Carbonara A. New HLA antigenic determinant shared by A2 and a subtype of Bw16 molecules detected by a monoclonal antibody. Human Immunol 1983; 7: 17–23
   PubMed Web of Science ®Google Scholar
• Goyert S M, Shively J E, Silver J. Biochemical characterization of second family of human la molecules, HLA-DS, equivalent to murine I-a subregion molecules. J Exp Med 1982; 156: 550–566
   PubMed Web of Science ®Google Scholar
• Tanigaki N, Tosi R. The genetic control of human la alloantigens: A three-loci model derived from the immunochemical analysis of “Supertypic” specificities. Immunol Rev 1982; 66: 5–37
   PubMed Web of Science ®Google Scholar
• Shackelford D A, Mann D L, Van Rood J J, et al. Human B-cell alloantigens DC1, MT1 and LB 12 are identical to each other but distinct from the HLA-DR antigen. Proc Natl Acad Sci USA 1981; 78: 4566–4570
   PubMed Web of Science ®Google Scholar
• Hurley C K, Shaw S, Nadler L, et al. Alpha and beta chains of SB and DR antigens are stucturally distinct. J Exp Med 1982; 156: 1557–1562
   PubMed Web of Science ®Google Scholar
• Pollack M S. The detection of weak allogeneic stimulation by DR positive tumor cell lines. Transplant Proc 1981; 13: 1947–1950
   PubMed Web of Science ®Google Scholar
• Pawelec G, Blaurock M, Schneider E M, et al. Alloactivated long-term culture human T lymphocytes express both HLA-DR and SB antigens but lack lymphocyte stimulation capacity. Eur J Immunol 1982; 12: 967–972
   PubMed Web of Science ®Google Scholar
• Danilovs J A, Ayoub G, Terasaki P I. B lymphocyte isolation by thrombin-nylon wool. Histocompatibility Testing, P I Terasai. UCLA Tissue Typing Laboratory, Los Angeles, CA 1980; 287
   Google Scholar
• Sorrentino R, Tanigaki N, Tosi R, Corte G. A current view of the human la system based on serological and immunochemical analysis. Human Immunol 1983; 8: 45–51
   PubMed Web of Science ®Google Scholar
• Goyert S M, Moriuchi J, Winchester R, Silver J. HLA-DS molecules and their relation to supertypic specificities. Human Immunol 1983; 8: 53–63
   PubMed Web of Science ®Google Scholar
• Gonwa T A, Picker L J, Raff H V, et al. Antigen-presenting capabilities of human monocytes correlates with their expression of HLA-DS, an la determinant distinct from HLA-DR. J Immunol 1982; 130: 706–711
   Web of Science ®Google Scholar
• Shaw S, Johnson A H, Shearer G M. Evidence for a new segregant series of B cell antigens that are encoded in the HLA-D region and that stimulate secondary allogeneic proliferative and cytotoxic responses. J Exp Med 1980; 152: 565–580
   PubMed Web of Science ®Google Scholar
• Pawelec S, Shaw S, Schneider M, et al. Population studies of HLA-linked SB antigens and their relative importance in primary MLC typing; Analysis of HLA-D homozygous typing cells and normal heterozygous populations. Human Immunol 1982; 5: 215–223
   PubMed Web of Science ®Google Scholar
• Ting A, Morris P J. Matching for B cell antigen of the HLA-DR series in cadaver renal transplantation. Lancet 1978; 1: 575–577
   PubMed Web of Science ®Google Scholar
• Thorsby E, Moen T, Solhein B G, et al. Influence of HLA matching in cadaveric renal transplantation: Experience from one Scandiatransplant center. Tissue Ant 1981; 17: 83–90
   PubMed Web of Science ®Google Scholar
• Lilly F, Boyse E A, Old L J. Genetic basis of susceptibility of viral leukemegenesis. Lancet 1964; 2: 1207
   PubMed Web of Science ®Google Scholar
• HLA and Disease Registry, L P Ryder, E Andersen, A Svejgaard. Munksgaard, Copenhagen 1979
   Google Scholar
• Sullivan J S, Prendergast J K, Geczy A F. Hypothesis: The etiology of ankylosing spondylitis: Does a plasmid trigger the disease in genetically susceptible individuals?. Human Immunol 1983; 6: 185–187
   PubMed Web of Science ®Google Scholar
• Uhr J W, Capra J D, Vitteta E S, et al. Organization of the immune response genes. Science 1979; 206: 292–297
   PubMed Web of Science ®Google Scholar
• Betuel H, Gebuhrer L, Descos L, et al. Adult celiac disease associated with HLA- DRw3 and -DRw7. Tissue Ant 1980; 15: 231–238
   PubMed Web of Science ®Google Scholar
• Pollack M S, Safai B, Dupont B. HLA-DR5 and DR2 are susceptibility factors for acquired immunodeficiency syndrome with Kaposi's sarcoma in different ethnic subpopulations. Dis Mark 1983; 1: 135–139
   Google Scholar
• Safai B, Myskowksi P L, Dupont B, Pollack M S. Association of HLA-DR5 with mycosis fungoides. J Invest Dermat, in press
   Google Scholar
• Winchester R, Toguchi T, Szer I, et al. Association of susceptibility to certain hematopoietic malignancies with the presence of la allodeterminants distinct from the DR series; Utility of monoclonal antibody reagents. Immunol Rev 1983; 70: 155–166
   PubMed Web of Science ®Google Scholar
• Dewolfe W C, Lange P H, Shepard R, et al. Association of HLA and renal cell carcinoma. Human Immunol 1981; 1: 41–44
   Google Scholar
• Aiginger P, Schwarz H P, Kumits R, et al. HLA-A,B,C and DR antigens and testicular cancer: A prospective study. Proc Am Assoc Cancer Res 1983; 190, (abstracts)
   Google Scholar
• Pollack M S, Vugrin D, Hennessy W, et al. HLA antigens in patients with germ cell cancer of the testis. Cancer Res 1982; 42: 2470–2473
   PubMed Web of Science ®Google Scholar
• Myskowski P L, Pollack M S, Schor E S, et al. HLA associations in basal cell carcinoma. Clin Res 1983; 31: 590A
   Google Scholar
• Terasaki P I, Perdue S T, Mickey M R. HLA frequencies in cancer: A second study. Genetics of Human Cancer, J J Mulvihill, R W Miller, J F Fraumeni, Jr. Raven Press, New York 1977; 321–328
   Google Scholar
• Baur M P, Danilovs J A. Reference tables of two and three locus haplotype frequencies for HLA-A,B,C,DR,Bf, and GLO. Histocompatibility Testing 1980, P I Terasaki. UCLA Tissue Typing Laboratory Los Angeles. 1980; 994–1210
   Google Scholar
• Hors J, Dausset J. HLA and susceptibility to Hodgkin's disease. Immunology 1983; 70: 167–191
   Google Scholar
• Batchelor J R, Morris P J. HLA and disease. Histocompatibility Testing 1977, W F Bodmer, J R Batchelor, J G Bodmer, H Festenstein, P J Morris. Tissue Typing Laboratory, Eds: UCLA, Los Angeles 1977; 205–258
   Google Scholar
• Svejgaard A, Platz P, Ryder L P. Insulin-dependent diabetes mellitus. Histocompatibility Testing 1980, P I Terasaki. UCLA Tissue Typing Laboratory, Los Angeles 1980; 638–656
   Google Scholar
• Dawkins R. Myasthenia gravis. Histocompatibility Testing 1980, P I Terasaki. UCLA Tissue Typing Laboratory, Los Angeles 1980; 662–667
   Google Scholar
• Ambinder J M, Chiorazzi N, Gibofsky A, Fotino M, Kunkel H G. Special characteristics of cellular immune function in normal individuals of the HLA-DR3 type. Clin Immunol Im-munopathol 1982; 23: 269–274
   PubMed Web of Science ®Google Scholar
• Gladman D D, Keystone E C, Baron M, et al. Increased frequency of HLA-DR5 in scleroderma. Arthritis Rhem 1981; 24: 854–856
   PubMed Web of Science ®Google Scholar
• Suciu-Foca N, Godfey M, Jacobs J, . Increased frequency of DRw5 in Pauciarticular JRA. Histocompatibility Testing 1980, P I Terasaki, et al. UCLA Tissue Typing Laboratory, Los Angeles 1980; 953
   Google Scholar
• Wakisaki A, Nakai Y, Kano T, . Complexity of DRw5 in Japanese. Histocompatibility Testing 1980, P I Terasaki, et al. UCLA Tissue Typing Laboratory, Los Angeles 1980; 806
   Google Scholar
• Curtoni E S, Borelli I, Cornaglia M, Olivetti E. Complexity of DRw5. Histocompatibility Testing 1980, P I Terasaki. UCLA Tissue Typing Laboratory, Los Angeles 1980; 805
   Google Scholar
• Engelfreit C, De Lange G, Hilterman T, Van Den Berg-Loonen D R. Histocompatibility Testing 1980, P I Terasaki. UCLA Tissue Typing Laboratory, Los Angeles 1980; 518–521
   Google Scholar
• Mizrachi Y, Orgad S, Jonash A, . DRw5 heterogeneity in the Jewish population. Histocompatibility Testing 1980, P I Terasaki, et al. UCLA Tissue Typing Laboratory, Los Angeles 1980; 807
   Google Scholar
• Gibofsky A, Winchester R J, Patarroya M, Fotino M, Kunkel H G. Brief definitive report: Disease associations of the la-like human alloantigens. J Exp Med 1978; 148: 1728–1732
   PubMed Web of Science ®Google Scholar
• Karpatkin S, Fotino M, Gibofsky A, Winchester R J. Association of HLA-DRw2 with autoimmune thrombocytopenic purpura. J Clin Invest 1979; 63: 1085–1088
   PubMed Web of Science ®Google Scholar
• Kimberly R P, Gibofsky A, Salmon J E, Fotino M. Brief definitive report: Impaired Fc-mediated mononuclear phagocyte system clearance in HLA-DR2 and Mil-positive healthy young adults. J Exp Med 1983; 157: 1698–1703
   PubMed Web of Science ®Google Scholar